Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study-Reference-Cited by-同舟云学术

Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study

Published:2016-07-26 Issue:11 Volume:19 Page:1083-1092
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Pal Sarvajeet¹,Veeravalli Sarath Chandra Mouli²,Das Siddharth Kumar³,Shobha Vineeta⁴,Uppuluri Ramakrishna Rao⁵,Dharmanand B G⁶,Nadkar Milind⁷,Hsia Elizabeth⁸,Fei Kaiyin⁸,Yao Ruji⁹,Khalifa Ahmed¹⁰

Affiliation:

1. Advance Rheumatology Clinic; Hyderabad India

2. Krishna Institute of Medical Sciences; Secunderabad India

3. Department of Rheumatology; RALC Campus; King George's Medical University; Lucknow India

4. St. John's Medical College Hospital; Bangalore India

5. Sri Deepti Rheumatology Centre; Hyderabad India

6. Chanre Rheumatology and Immunology Center and Research; Bangalore India

7. Department of Medicine; Seth G.S. Medical College & KEM Hospital; Mumbai India

8. Janssen Global R&D; J&J; Spring House PA USA

9. Biostatistics; Merck; Rahway NJ USA

10. MSD Medical Affairs; Luzern Switzerland

Funder

Janssen India

Johnson & Johnson Pvt. Ltd

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.12927/fullpdf

Reference23 articles.

1. Extra-articular manifestations and complications of rheumatoid arthritis;Young;Best Pract Res Clin Rheum,2007

2. Biologic agents in rheumatoid arthritis: an update for managed care professionals;Agarwal;J Manag Care Pharm,2011

3. 2012 Update of the 2008 American College of Rheumatology (ACR) Recommendations for the use of disease-modifying anti-rheumatic drugs and Biologics in the treatment of Rheumatoid Arthritis (RA);Singh;Arthritis Care Res (Hoboken),2012

4. Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor alpha;Shealy;MAbs,2010

5. Center for Drug Evaluation and Research http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/125289s000_SumR.pdf

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Golimumab in Rheumatoid Arthritis: A Prospective, Multicenter, Real-World Study from India;Indian Journal of Rheumatology;2023-07-14

3. A case of human leukocyte antigen B-27-associated ocular hypotony successfully treated with golimumab;Indian Journal of Ophthalmology;2018

4. Treatment interruption of biological drugs and tofacitinib in rheumatoid arthritis: A systematic review of case reports;Brazilian Journal of Pharmaceutical Sciences;2018